Shangping Xing

567 total citations
28 papers, 429 citations indexed

About

Shangping Xing is a scholar working on Molecular Biology, Pharmacology and Plant Science. According to data from OpenAlex, Shangping Xing has authored 28 papers receiving a total of 429 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 12 papers in Pharmacology and 6 papers in Plant Science. Recurrent topics in Shangping Xing's work include Biological and pharmacological studies of plants (8 papers), Ginseng Biological Effects and Applications (4 papers) and Traditional Chinese Medicine Analysis (3 papers). Shangping Xing is often cited by papers focused on Biological and pharmacological studies of plants (8 papers), Ginseng Biological Effects and Applications (4 papers) and Traditional Chinese Medicine Analysis (3 papers). Shangping Xing collaborates with scholars based in China, Australia and Sweden. Shangping Xing's co-authors include Gang Wei, Yuechun Huang, Zhouxi Lei, Ji Lin, Zhiyao Ren, Feifei Nong, Wenxia Yu, Chenxing Liu, Shengchang Tao and Yingyi Luo and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and Cellular and Molecular Life Sciences.

In The Last Decade

Shangping Xing

24 papers receiving 426 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shangping Xing China 12 234 174 155 49 44 28 429
Zhouxi Lei China 12 263 1.1× 232 1.3× 233 1.5× 22 0.4× 35 0.8× 15 485
Yingyi Luo China 8 193 0.8× 150 0.9× 136 0.9× 21 0.4× 23 0.5× 9 319
Chen Qing China 12 250 1.1× 95 0.5× 112 0.7× 86 1.8× 70 1.6× 24 511
Wen‐Luan Wendy Hsiao Hong Kong 15 244 1.0× 98 0.6× 94 0.6× 50 1.0× 26 0.6× 20 485
Dandan Lu China 10 339 1.4× 65 0.4× 172 1.1× 33 0.7× 35 0.8× 15 592
Ailin Yang China 14 242 1.0× 64 0.4× 63 0.4× 78 1.6× 70 1.6× 43 514
Wu Bi China 12 256 1.1× 36 0.2× 149 1.0× 52 1.1× 42 1.0× 22 471
Magdalena Dmoszyńska‐Graniczka Poland 14 329 1.4× 70 0.4× 60 0.4× 61 1.2× 87 2.0× 25 551
Tatiana Valachovicova United States 7 144 0.6× 184 1.1× 52 0.3× 56 1.1× 70 1.6× 7 426

Countries citing papers authored by Shangping Xing

Since Specialization
Citations

This map shows the geographic impact of Shangping Xing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shangping Xing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shangping Xing more than expected).

Fields of papers citing papers by Shangping Xing

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shangping Xing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shangping Xing. The network helps show where Shangping Xing may publish in the future.

Co-authorship network of co-authors of Shangping Xing

This figure shows the co-authorship network connecting the top 25 collaborators of Shangping Xing. A scholar is included among the top collaborators of Shangping Xing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shangping Xing. Shangping Xing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xing, Shangping, et al.. (2025). Lycobetaine Has Therapeutic Efficacy in Lung Squamous Cell Carcinoma by Targeting USP32 to Trigger Ferroptosis. Current Issues in Molecular Biology. 47(3). 163–163.
2.
Yang, Dongyun, Lin Zeng, Shu‐Yuan Liang, et al.. (2025). Aqueous extract of Evodia lepta Merr. attenuates influenza virus infection via inhibition of the HSP90/NF-κB axis. Journal of Ethnopharmacology. 353(Pt A). 120337–120337.
3.
Lin, Guosheng, Ziwei Xu, Shangping Xing, et al.. (2025). Proteomic screening identifies brusatol targets TGFβRII to suppresses non-small cell lung cancer metastasis. Phytomedicine. 139. 156468–156468.
4.
Ouyang, A., Xin Wang, Shangping Xing, et al.. (2025). A Novel pH‐Responsive Baicalein@Chitosan Hydrogel for the Topical Treatment of Herpes Simplex Virus Type 1 Skin Infections: Therapeutic Potential and Mechanisms. Advanced Healthcare Materials. 14(11). e2403961–e2403961. 1 indexed citations
5.
Nong, Feifei, et al.. (2025). Zuojin Wan Suppresses the Progression of Colorectal Cancer by Inhibiting M2 Tumor-Associated Macrophages Through JAK2/STAT3 Signaling Pathway and In Vivo and In Vitro. Integrative Cancer Therapies. 24. 1583691087–1583691087. 1 indexed citations
6.
Yang, Dan, Qinhong Luo, Mingyu Huang, et al.. (2024). Ras-Targeting Stabilized Peptide Increases Radiation Sensitivity of Cancer Cells. Bioconjugate Chemistry. 35(6). 737–743. 1 indexed citations
7.
Yang, Chunxia, Shangping Xing, Genshi Zhao, et al.. (2024). 12-O-deacetyl-phomoxanthone A inhibits ovarian tumor growth and metastasis by downregulating PDK4. Biomedicine & Pharmacotherapy. 175. 116736–116736. 4 indexed citations
8.
Xing, Shangping, Wei Xia, Chunxia Yang, et al.. (2024). Elucidating the role of 4-hydroxy-2(3H)-benzoxazolone in chronic alcoholic liver disease via transcriptomics and metabolomics. Frontiers in Pharmacology. 15. 1447560–1447560. 1 indexed citations
9.
10.
Li, Li, et al.. (2022). KIAA1199 Correlates With Tumor Microenvironment and Immune Infiltration in Lung Adenocarcinoma as a Potential Prognostic Biomarker. Pathology & Oncology Research. 28. 1610754–1610754. 3 indexed citations
11.
Xing, Shangping, Feifei Nong, Yaqin Wang, et al.. (2022). Brusatol has therapeutic efficacy in non-small cell lung cancer by targeting Skp1 to inhibit cancer growth and metastasis. Pharmacological Research. 176. 106059–106059. 26 indexed citations
12.
Xing, Shangping, et al.. (2021). Gentiopicroside Produces Endothelium‐Independent Vasodilation by Deactivating the PI3K/Akt/Rho‐Kinase Pathway in Isolated Rat Thoracic Aorta. BioMed Research International. 2021(1). 5565748–5565748. 6 indexed citations
13.
Huang, Jiahui, Chenxing Liu, Ji Lin, et al.. (2021). Gigantol inhibits proliferation and enhances DDP-induced apoptosis in breast-cancer cells by downregulating the PI3K/Akt/mTOR signaling pathway. Life Sciences. 274. 119354–119354. 24 indexed citations
14.
Ren, Zhiyao, Yinjie Wang, Wenxia Yu, et al.. (2020). Network Analysis of Transcriptome and LC‐MS Reveals a Possible Biosynthesis Pathway of Anthocyanins in Dendrobium officinale. BioMed Research International. 2020(1). 6512895–6512895. 18 indexed citations
15.
Nong, Feifei, Shuang Luo, Yuqi Liang, et al.. (2020). Evaluation of the effect of Dahuang–Mudan decoction on TNBS‐induced colitis using UPLC–QTOF/MS‐based metabolomic analysis. Biomedical Chromatography. 35(3). e5003–e5003. 10 indexed citations
16.
Wang, Kun, Jianyong Xiao, Xiaodong Liu, et al.. (2019). AICD: an integrated anti-inflammatory compounds database for drug discovery. Scientific Reports. 9(1). 7737–7737. 16 indexed citations
17.
18.
19.
Yu, Wenxia, Zhiyao Ren, Xiaofeng Zhang, et al.. (2018). Structural Characterization of Polysaccharides from Dendrobium officinale and Their Effects on Apoptosis of HeLa Cell Line. Molecules. 23(10). 2484–2484. 47 indexed citations
20.
Xing, Shangping, et al.. (2017). Paeonol attenuates aging MRC-5 cells and inhibits epithelial–mesenchymal transition of premalignant HaCaT cells induced by aging MRC-5 cell-conditioned medium. Molecular and Cellular Biochemistry. 439(1-2). 117–129. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhouxi Lei Breakdown of academic impact, for papers by Yingyi Luo Breakdown of academic impact, for papers by Chen Qing Breakdown of academic impact, for papers by Wen‐Luan Wendy Hsiao Breakdown of academic impact, for papers by Dandan Lu Breakdown of academic impact, for papers by Ailin Yang Breakdown of academic impact, for papers by Wu Bi Breakdown of academic impact, for papers by Magdalena Dmoszyńska‐Graniczka Breakdown of academic impact, for papers by Tatiana Valachovicova
Rankless by CCL
2026